Welcome to our dedicated page for Microvision SEC filings (Ticker: MVIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MicroVision's SEC filings document material events for a lidar-based perception company serving automotive, industrial, and security and defense markets. Current reports describe operating results, business updates, investor presentations, and product and market disclosures tied to the company's lidar sensor portfolio and perception software.
Recent filings also record the completed acquisition of certain Luminar lidar sensor business assets, including required historical financial statements and unaudited pro forma financial information. Other disclosures cover senior secured convertible notes due 2028, exchanges and purchases of convertible debt, direct common stock sales to directors and executive officers, Nasdaq-related share issuance considerations, governance matters, and Regulation FD communications.
MicroVision, Inc. registers for resale up to 61,315,970 shares of common stock issuable upon conversion of senior secured convertible notes due 2028. The shares are being registered for the selling stockholders; the company will not receive any proceeds from resales. The registration reflects Convertible Notes with an initial conversion price of $0.8819 per share and an aggregate principal amount of approximately $43 million. The prospectus discloses 326,982,727 shares outstanding as of April 20, 2026 and states a post-offering hypothetical outstanding share count of 388,298,697 if all Shares are issued. The Convertible Notes include a 4.99% beneficial ownership limitation (increaseable to 9.99% with notice), optional monthly partial redemptions, a Forced Conversion trigger tied to a sustained VWAP > $2.00, and secured, senior ranking collateral. This prospectus covers resale mechanics, permitted sale methods, and customary plan-of-distribution language.
MicroVision, Inc. files a pre-effective Amendment No. 1 to register for resale up to 61,315,970 shares of common stock underlying senior secured convertible notes due 2028 (the "Convertible Notes") held by High Trail Special Situations LLC and High Trail Special Situations II LLC. The registrant will receive no proceeds from resales. The shares are issuable upon conversion of Convertible Notes issued in a private placement on February 23, 2026, which aggregate principal was approximately $43 million. The Convertible Notes include an initial conversion price of $0.8819 per share, a 4.99% beneficiary ownership limit (increaseable to 9.99% with notice), monthly partial redemptions at holder election, and a Forced Conversion feature tied to a $2.00 VWAP trigger. Shares outstanding were 326,982,727 as of April 20, 2026; assuming conversion of all registered Shares, the prospectus states 388,298,697 shares outstanding. The prospectus discloses risks related to volatility, dilution, secured debt, liquidity covenants and collateralized bank and securities accounts.
MicroVision, Inc. filed Amendment No. 1 to its Form 10-K for the year ended December 31, 2025 to add updated Part III information, because its 2026 proxy will not be filed in time for incorporation by reference. The amendment does not change previously reported financial statements.
The filing refreshes details on the board and leadership, including CEO and director Glen DeVos, Executive Vice Chair Simon Biddiscombe, and other independent directors, along with committee roles and independence determinations. It outlines executive and director pay, showing a strong emphasis on equity-based compensation, bonus targets tied to revenue, cash operating expenses, and strategic objectives, plus “pay versus performance” data driven largely by stock price.
The amendment also discloses major shareholders such as BlackRock and State Street, insider and director stock ownership, a related-party employment arrangement involving the CEO’s brother-in-law, and fees paid to independent auditor Baker Tilly for audit, audit-related, and tax services.
MicroVision, Inc. registers up to 61,315,970 shares of common stock underlying senior secured convertible notes due 2028 (the "Convertible Notes"). These Shares are issuable upon conversion of the Convertible Notes and are being registered for resale by the selling stockholders.
The company will receive no proceeds from sales by the selling stockholders. The prospectus discloses 326,982,727 shares outstanding as of April 20, 2026 and states a pro forma figure of 388,298,697 common shares outstanding assuming all Shares offered herein are issued pursuant to conversion of the Convertible Notes.
MicroVision, Inc. filed an amended report to provide full financial details for its acquisition of Luminar Technologies’ LiDAR sensor business. MicroVision completed the asset purchase on February 3, 2026 under a January 26, 2026 agreement and paid total cash consideration of $33.2 million, including cure costs.
The filing adds audited carved‑out financials for the Luminar LiDAR Business and unaudited pro forma results. The acquired business generated $40.976 million of revenue in 2025 but reported a net loss of $280.7 million, following a $396.0 million loss in 2024. Its 2025 results include a $42.8 million loss on firm purchase commitments and $21.7 million of restructuring and other costs.
The auditor’s report highlights substantial doubt about the Luminar LiDAR Business’s ability to continue as a going concern due to the Parent’s recurring losses and Chapter 11 bankruptcy. As of December 31, 2025, $78.4 million of pre‑petition obligations were classified as liabilities subject to compromise, and reorganization items of $3.5 million were recorded in 2025.
MicroVision Interim CFO Stephen Hrynewich reported routine equity compensation activity. On April 6, 2026, vested restricted stock units (RSUs) converted into 4,800 shares of common stock on a unit-for-share basis, without cash payment.
On April 8, 2026, the company completed a tax-related, nondiscretionary sell-to-cover transaction, withholding 1,555 shares of common stock at a weighted average price of $0.6289 per share to satisfy tax obligations under the award agreement. Following these transactions, Hrynewich directly owns 175,337 shares of MicroVision common stock.
MicroVision, Inc. furnished a new investor presentation under Regulation FD. The presentation, dated April 2026, is available on the company’s investor relations website and is attached as Exhibit 99.1. MicroVision expects to use this deck, in whole or in part, in presentations to investors, analysts and others throughout 2026.
The company states that the information in the presentation is summary in nature and should be read together with its SEC filings and other public announcements. The material is being furnished, not filed, so it is not subject to certain Exchange Act liabilities and will not be automatically incorporated into Securities Act registration statements.
MICROVISION, INC. CEO Glen W. DeVos reported routine equity compensation activity involving restricted stock units and related tax withholding. On March 31, 2026, 325,000 vested restricted stock units converted into an equal number of common shares. On April 2, 2026, the company completed a tax-related nondiscretionary sell-to-cover transaction, withholding 153,230 common shares at a weighted average price of $0.6403 per share in multiple trades between $0.6402 and $0.6408. Following these transactions, DeVos directly holds 359,670 shares of MicroVision common stock. The filing reflects compensation vesting and tax settlement rather than open-market buying or selling by the CEO.
The Vanguard Group filed Amendment No. 3 to Schedule 13G/A reporting 0 shares of MicroVision Inc. common stock as beneficially owned. The filing explains an internal realignment and disaggregation under SEC Release No. 34-39538 (January 12, 1998), with certain subsidiaries reporting separately. The amendment is signed by Ashley Grim on 03/27/2026.